Virtual Meeting to be held on March 18 hosted by Truist.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLO:
- Allogene Therapeutics’ Earnings Call Highlights Progress
- Promising Pipeline and Upcoming Data Releases Drive Buy Rating for Allogene Therapeutics
- Allogene upgraded to Outperform from Market Perform at Citizens JMP
- Promising Developments in Allogene Therapeutics’ Cema-cel Therapy Highlighted by Phase I Data and Upcoming ALPHA3 Trial
- Promising Potential and Strategic Growth: A Buy Rating for Allogene Therapeutics